Showing 16,901 - 16,920 results of 44,577 for search '(( 5 ((026 decrease) OR (mean decrease)) ) OR ( 50 ((c decrease) OR (a decrease)) ))', query time: 1.40s Refine Results
  1. 16901

    Conformational characterization of a novel anti-HER2 candidate antibody by Leina Moro Pérez (6686177)

    Published 2019
    “…In this work, the conformational features of a novel monoclonal antibody (called 5G4) were evaluated by means of circular dichroism spectroscopy and fluorescence. …”
  2. 16902
  3. 16903
  4. 16904
  5. 16905
  6. 16906

    The limits of olfactory perception in black vultures: a field experiment by Larissa H. Santos (12466783)

    Published 2022
    “…The probability of reaction decreased significantly with the distance between the birds and the fish bait, being virtually null at 40–50 m away. …”
  7. 16907

    Supplementary Material for: Changes in migraine symptoms after ischemic stroke: a cohort study by vanderWeerd N. (18602434)

    Published 2024
    “…Results We included 78 patients (mean age 48 years, 86% women, 47% with aura). Change in migraine symptomatology was reported by 63 (81%) patients; 51 (81%) noticed a decrease in attack frequency (27 no attacks), and 12 (19%) an increase. …”
  8. 16908
  9. 16909

    Chemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin Fluctuation by Yu-Jen Chao (665872)

    Published 2016
    “…Methotraxate treatment caused unique increases of acyl chain length on CL, which were the opposite of the serum starvation, mitomycine C and vincristine treatments. Although mitomycine C and vincristine have different mechanisms to induce cell cycle arrest, these two drugs displayed similar effects on decreasing chain length of CL. …”
  10. 16910

    Anthraquinone G503 Induces Apoptosis in Gastric Cancer Cells through the Mitochondrial Pathway by Lijun Huang (636735)

    Published 2014
    “…In consideration of the lower 50% inhibitory concentration for gastric cancer cells, G503 may serve as a promising candidate for gastric cancer chemotherapy.…”
  11. 16911

    MOR activation inhibits glutamate release onto a subset of LHb neurons. by Elyssa B. Margolis (148265)

    Published 2016
    “…Scale bars 25% and 5 min. (C) Example traces from a neuron where DAMGO decreased the frequency, but not the amplitude, of sEPSCs. …”
  12. 16912

    The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial by Jin-Chao Song (5963936)

    Published 2018
    “…The clearance of dexmedetomidine in patients with severe hepatic failure decreased by 50% compared with controls. We tested the hypothesis that the pharmacokinetics of dexmedetomidine would be affected by obstructive jaundice. …”
  13. 16913
  14. 16914
  15. 16915
  16. 16916
  17. 16917
  18. 16918
  19. 16919
  20. 16920